文献速递生殖医学

以患者为中心的不孕症诊疗是未来方向

Patient-tailored infertility care is the way forward.
PubMed 文献 · Reprod Biomed Online · 2022-06-23

本文讨论不孕症诊疗中标准化实践与个体化诊疗的争议,指出两者各有侧重,现有随机对照试验证据不足以判定孰优孰劣,有建议认为N-of-1试验更适合评估个体化诊疗,并强调全球不孕患者仍存在治疗不足,需更个体化的方法以优化结局并满足患者偏好。

要点

  • 标准化诊疗追求平均人群的效率,个体化诊疗整合临床经验与患者权利和偏好。
  • 现有随机对照试验证据被认为不足以明确判定标准化或个体化诊疗孰优孰劣。
  • 全球不孕患者仍存在治疗不足,原因包括结局不佳、担心不良事件和经济因素。

核心结论

  • 标准化与个体化诊疗孰优孰劣的现有证据尚存争议且过于薄弱,不足以明确宣称一方优于另一方。
  • 有建议认为随机对照试验并非评估个体化诊疗效果的最佳工具,N-of-1试验被提出作为最合适的方法。
  • 全球不孕患者仍存在治疗不足,需要更个体化的方法以在优化结局的同时满足患者偏好。

研究设计与样本

  • 本文为论述性文章,比较不孕症领域中标准化诊疗与个体化诊疗两种模式,并讨论评估个体化诊疗的研究设计。

主要发现

  • 标准化诊疗追求平均人群诊断与治疗流程的效率并以循证医学为支持,个体化诊疗追求以患者为中心的诊疗并整合个体临床经验与患者权利和偏好。
  • 少数以活产率和不良事件发生率为终点的随机对照试验比较了两种方法,但现有证据存有争议且过于薄弱,不足以明确判定一方优于另一方。
  • 有建议认为作为循证医学基石的随机对照试验并非评估个体化诊疗效果的最佳工具,N-of-1试验被提出作为最合适的方法。
  • 全球不孕患者仍存在治疗不足,结局不佳、担心不良事件和经济因素是其背后原因。

临床怎么用

  • 作者认为,需要更个体化的方法以在优化结局的同时满足患者偏好,从而克服治疗不足的障碍。

局限性

  • 现有比较标准化与个体化诊疗的随机对照试验证据存有争议且过于薄弱,不足以明确判定一方优于另一方。
  • 有建议认为随机对照试验并非评估个体化诊疗效果的最佳工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As in any other healthcare discipline, the debate around standardization of practice versus individualized care is also present in the field of infertility. While the former looks for the efficiency of diagnostic and therapeutic processes in the average population supported by evidence-based medicine (EBM), the later looks for patient-centred care, integrating individual clinical expertise and patients' rights and preferences. Both approaches have been compared in a few randomized controlled trials (RCT) having as end-points live birth rates and incidences of adverse effects. However, the available evidence is arguable and too weak to clearly proclaim that one is better than the other. Indeed, it has been suggested that RCT, the keystone of EBM, are not the best tools to evaluate the efficacy of personalized care. A different design, named 'N-of-1' trials, has been proposed as the most appropriate methodology to this end. Infertile patients are still undertreated worldwide. Poor outcomes, fear of adverse events and financial reasons are behind this. In this context, a more personalized approach, aimed at optimizing the outcome while fulfilling the patient's preferences, is necessary to overcome these barriers.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Bosch E. Patient-tailored infertility care is the way forward. Reprod Biomed Online. 2022. PMID: 35934638. doi:10.1016/j.rbmo.2022.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。